R1 Therapeutics
R1 Therapeutics is a clinical-stage biopharmaceutical company that develops first-in-class treatments for kidney disease patients.
$80.5M Series A ·
Led by Samsara Biocapital · Source: clinicaltrialsarena.com
Total raised: $158M across 2 sourced rounds
All 2 rounds ↓Signals
R1 Therapeutics | 176 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $80.5M | clinicaltrialsarena.com | ||
| Series A | $77.5M | pharmiweb.com |
Timeline
- Website created
Founders and team
KP
Krishna Polu FounderLM
L. Mary Smith Founder
Investors
AAbingworthlead investor
CCurie.Bio
DDaVita Venture Grouplead investor
FF-Prime Capitallead investor
SSamsara Biocapitallead investor
SSymBiosis
UU.S. Renal Care
Companies like R1 Therapeutics
PProtego$130M Series B+ · Dec 2025
OOncusp TherapeuticsSeries A · Nov 2025TTargED BiopharmaceuticalsSeries A · Jul 2025
AAdiposs$5.02M Series A · Jul 2025
AAdjuvia Therapeutics$8M Seed · Jul 2026
AApollo Therapeutics$226.5M Series B+ · Sep 2023
Other companies backed by Samsara Biocapital
TT-Therapeutics$133M Series B+ · Nov 2026
AAbcuro$66M Series B+ · Aug 2026
CClaris Bio$118M Series B+ · Jul 2026
NNura Bio$73.8M Series B+ · Jun 2026
PPsiThera$47.5M Series A · Dec 2025
SSidera Bio$109.99M Series A · Nov 2025
Samsara Biocapital portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/r1-therapeutics (get a free API key).